Volumetric-modulated arc therapy for a pelvic lymph node metastasis from prostate cancer: a case report

A 50-year-old patient had an early biochemical recurrence after radical prostatectomy and androgen deprivation therapy and castration. An anti-1-amino-3-[¹⁸F] fluorocyclobutane-1-carboxylic acid positron emission tomography/computed tomography scan showed a single pelvic lymph node metastasis. The patient was given volume-modulated arc therapy with a cumulative dose of 50 Gy for the volume with pelvic lymph nodes and 78 Gy to the boost volume for the lymph node metastasis. He experienced only a transitory mild toxicity from the rectum and the urinary bladder and had a partial remission for 16 months.